Based on our data, we believe that the RESILIENCE trial would have achieved better outcome for the patients if it were designed to treat HR+ patients with Sorafenib together with hormonal therapy versus Placebo with hormonal therapy
Treatment with sulforaphane significantly reduced expression of key glycolytic genes, including hexokinase II and pyruvate kinase M2, in prostate cancer cell lines, LNCaP, 22RV1, and PC-3, and in transgenic mouse models, TRAMP and Hi-Myc (Singh et al., 2019)
GHK-Cu is a copper peptide that may improve the appearance of skin texture and supports healthier looking hair and scalp
Mechanistic studies typically combine receptor or cell-based assays with analytical verification of peptide identity and integrity
When bacteria are killed off, they release toxins into the gut